Home › Astrocytoma › Texas › Houston
Pag-aaral pangklinika para sa Astrocytoma sa Houston, TX
14 pag-aaral para sa Astrocytoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Houston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Nagre-recruitPhase 1
- M D Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
- MD Anderson Cancer Center, Houston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Research Site, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Nagre-recruitPhase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Nagre-recruitPhase 2
- M D Anderson Cancer Center, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nagre-recruitPhase 2
- Texas Children's Hospital, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Nagre-recruitPhase 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Nagre-recruitPhase 1/2
- Houston Methodist Neurological Institute, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
- UT MD Anderson Cancer Center, Houston
Pag-aaral para sa Astrocytoma sa ibang lungsod
- Boston, MA13 pag-aaral
- Chicago, IL9 pag-aaral
- New York City, NY9 pag-aaral
- Philadelphia, PA7 pag-aaral
- Miami, FL7 pag-aaral
- Columbus, OH6 pag-aaral
- Washington, DC6 pag-aaral
- Seattle, WA6 pag-aaral
- Durham, NC6 pag-aaral
- San Francisco, CA6 pag-aaral
- Aurora, CO5 pag-aaral
- Cincinnati, OH5 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)121 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer102 pag-aaral
- Kanser sa Ovary89 pag-aaral
- Acute Myeloid Leukemia85 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium68 pag-aaral
- Kanser sa Pancreas61 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.